Related Experiment Video
Updated: Nov 2, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Navigating the DNA methylation landscape of cancer
Atsuya Nishiyama1, Makoto Nakanishi1
1Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Abstract:
DNA methylation is a chemical modification that defines cell type and lineage through the control of gene expression and genome stability. Disruption of DNA methylation control mechanisms causes a variety of diseases, including cancer. Cancer cells are characterized by aberrant DNA methylation (i.e., genome-wide hypomethylation and site-specific hypermethylation), mainly targeting CpG islands in gene expression regulatory elements. In particular, the early findings that a variety of tumor suppressor genes (TSGs) are targets of DNA hypermethylation in cancer led to the proposal of a model in which aberrant DNA methylation promotes cellular oncogenesis through TSGs silencing. However, recent genome-wide analyses have revealed that this classical model needs to be reconsidered. In this review, we will discuss the molecular mechanisms of DNA methylation abnormalities in cancer as well as their therapeutic potential.
Insights
DNA methylation abnormalities, including hypomethylation and hypermethylation, are hallmarks of cancer. Aberrant DNA methylation, particularly targeting tumor suppressor genes, requires a reevaluation of its role in oncogenesis and therapeutic strategies.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- DNA methylation is crucial for cell identity and gene regulation.
- Disruptions in DNA methylation contribute to diseases like cancer.
- Cancer cells exhibit abnormal DNA methylation patterns, affecting gene expression.
Purpose of the Study:
- To review the molecular mechanisms of DNA methylation abnormalities in cancer.
- To discuss the therapeutic potential of targeting aberrant DNA methylation.
- To re-evaluate the classical model of DNA methylation's role in oncogenesis.
Main Methods:
- Review of recent genome-wide analyses.
- Analysis of molecular mechanisms.
- Discussion of therapeutic strategies.
Main Results:
- Cancer cells display genome-wide hypomethylation and site-specific hypermethylation.
- Aberrant DNA methylation targets CpG islands in regulatory elements.
- The classical model of tumor suppressor gene silencing needs reconsideration.
Conclusions:
- DNA methylation abnormalities are central to cancer development.
- Understanding these mechanisms offers therapeutic opportunities.
- Further research is needed to refine models and develop treatments.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

